Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Capital Expenditures (2023 - 2025)

BrightSpring Health Services' Capital Expenditures history spans 3 years, with the latest figure at $92.6 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 19.8% year-over-year to $92.6 million; the TTM value through Dec 2025 reached $95.5 million, up 18.01%, while the annual FY2025 figure was $95.5 million, 18.01% up from the prior year.
  • Capital Expenditures reached $92.6 million in Q4 2025 per BTSG's latest filing, up from -$1.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $92.6 million in Q4 2025 to a low of -$43.7 million in Q4 2023.
  • Average Capital Expenditures over 3 years is $15.8 million, with a median of $5.4 million recorded in 2023.
  • The largest YoY upside for Capital Expenditures was 611.55% in 2024 against a maximum downside of 358.54% in 2024.
  • A 3-year view of Capital Expenditures shows it stood at -$43.7 million in 2023, then surged by 276.89% to $77.3 million in 2024, then rose by 19.8% to $92.6 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Capital Expenditures are $92.6 million (Q4 2025), -$1.2 million (Q3 2025), and -$13.5 million (Q2 2025).